A team at Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital has successfully completed the first Barostim Baroreflex Activation Therapy implant in the state of Minnesota, according to an announcement from CVRx, Inc. and Allina Health. Barostim is the world’s first FDA-approved neuromodulation heart failure device, which works by stimulating baroreceptors, natural sensors located in the wall of the carotid artery.
Sean Whooley massdevice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massdevice.com Daily Mail and Mail on Sunday newspapers.
By Rob Curran Medical-device maker CVRx named board member Kevin Hykes president and chief executive, effective Feb. 12, at which time current President and.
CVRx, Inc. (NASDAQ:CVRX) Q4 2023 Earnings Call Transcript January 25, 2024 CVRx, Inc. beats earnings expectations. Reported EPS is $-0.44, expectations were $-0.55. CVRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the CVRx Fourth Quarter […]